Diabetic neuropathy and role of biochemical parameters in diabetic neuropathy
A narrative review
Keywords:
diabetes mellitus (DM), hemoglobin A1C (HbA1C), diabetic neuropathy (DN), DPN, VEGFAbstract
Diabetic neuropathy (DN) is the most widely recognized and distressing microvascular manifestation of diabetes, prompting the best degree of morbidity and mortality and bringing about an enormous financial weight for diabetes care. One of the major causesin DN is uncontrolled diabetes or hyperglycemia followed by nerve damage. The severity of DN is primarily associated with age, sex, plasma glucose level, hemoglobin A1C(HbA1C)value, length ofdiabetes, and Body Mass Index (BMI). The clinical assessment of peripheral neuropathy and its alternative treatments are multifactorial. The angiogenic proteinvascular endothelialgrowthfactor (VEGF) contributes a significant role in DN. Thus this review article presents knowledge about the different perspective soft hedisease, incidence epidemiology, pathophysiology, and the organ which are affected, diagnosis, prognosis followed by management of DN. The early diagnosis of diabetic neuropathies may help to reduce the severity of the disease as well the biochemical parameters involved in diabetic neuropathy can give a clear picture about the patient physical as well as the neurological status and protein like VEGF estimation can be used as a good predictor of Diabetic neuropathy.
Downloads
References
2016 Foundation for Peripheral Neuropathy International Research Symposium: Advances in Neuropathy - Emerging Therapies. J Peripher Nerv Syst 2017; 00: 1–24.
Alvarez JA, Ashraf A. Role of Vitamin D in Insulin Secretion and Insulin Sensitivity for Glucose Homeostasis. Int J Endocrinol 2010; 2010: 1–18.
Anand AV, Bharathi V, Bupesh G, et al. Identification of novel potent pancreatic lipase inhibitors from Ficus racemosa. Biomedicine 2021; 41: 23–30.
Anjana RM, Deepa M, Pradeepa R, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. Epub ahead of print 2017. DOI: 10.1016/S2213-8587(17)30174-2.
Anju M, Chacko L, Chettupalli Y, et al. Effect of Low Level Laser Therapy on serum vitamin D and magnesium levels in patients with diabetic peripheral neuropathy – A pilot study. Diabetes Metab Syndr Clin Res Rev 2019; 13: 1087–1091.
Barbagallo M. Magnesium and type 2 diabetes. World J Diabetes 2015; 6: 1152.
Barrientos S, Brem H, Stojadinovic O, et al. Clinical application of growth factors and cytokines in wound healing. Wound Repair Regen 2014; 22: 569–78.
Bowser-Riley F, House CR. The actions of some putative neurotransmitters on the cockroach salivary gland. J Exp Biol 1976; 64: 665–76.
Bril V, England J, Franklin GM, et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76: 1758–1765.
Bril V, Perkins BA. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 2002; 25: 2048–52.
Bril V, Tomioka S, Buchanan RA, et al. Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy. Diabet Med 2009; 26: 240–246.
Darivemula S, Nagoor K, Patan SK, et al. Prevalence and Its Associated Determinants of Diabetic Peripheral Neuropathy (DPN) in Individuals Having Type-2 Diabetes Mellitus in Rural South India. Indian J Community Med 2019; 44: 88–91.
DHHS. National Diabetes Statistics Report, 2020. Natl Diabetes Stat Rep.
Farsi L, Naghib Zadeh M, Afshari K, et al. Effects of combining methylprednisolone with magnesium sulfate on neuropathic pain and functional recovery following spinal cord injury in male rats. Acta Med Iran 2015; 53: 149–57.
Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Prim 2019; 5: 41.
Fisher L, Hessler DM, Polonsky WH, et al. When is diabetes distress clinically meaningful?: establishing cut points for the Diabetes Distress Scale. Diabetes Care 2012; 35: 259–64.
Good to Know: Nerve Damage and Diabetes. Clin Diabetes 2019; 37: 391–392.
Günther T. Magnesium in bone and the magnesium load test. Magnes Res 2011; 24: 223–224.
Gupta P, Verma N, Bhattacharya S, et al. Association of Diabetic Autonomic Neuropathy with Red Blood Cell Aldose Reductase Activity. Can J Diabetes 2014; 38: 22–25.
Joy SS, George TP, Siddiqui K. Low magnesium level as an indicator of poor glycemic control in type 2 diabetic patients with complications. Diabetes Metab Syndr Clin Res Rev 2019; 13: 1303–1307.
Kawano T. A Current Overview of Diabetic Neuropathy – Mechanisms, Symptoms, Diagnosis, and Treatment. In: Peripheral Neuropathy. InTech, 2014, pp. 1–105.
M. Nagarajan Meenakshi Sundaram, K and M. Sundararaman RR. Marine Biotechnology: Potentials of Marine Microbes and Algae with Reference to Pharmacological and Commercial Values. In: Plant Biology and Biotechnology. Springer New Delhi, 2015, p. pp-685.
Mahardika, I. M. R., Suyasa, I. G. P. D., Kamaryati, N. P., & Wulandari, S. K. (2021). Health literacy is strongest determinant on self-monitoring blood glucose (SMBG) type 2 DM patients during COVID-19 pandemic at public health centre in Tabanan Regency. International Journal of Health & Medical Sciences, 4(3), 288-297. https://doi.org/10.31295/ijhms.v4n3.1752
Manivannan C, Meenakshi Sundaram K, Sundararaman M, et al. Investigation on the inclusion and toxicity of acriflavine with cyclodextrins: A spectroscopic approach. Spectrochim Acta - Part A Mol Biomol Spectrosc 2014; 122: 164–170.
Manivannan C, Saravanamoorthy S, Meenakshisundaram K. Investigation on the Intercalation and Toxicity of 9-Aminoacridine in Zinc/Aluminium Layered Double Hydroxide Nanocomposites with Controlled Release Properties. J Bionanoscience 2017; 11: 482–488.
Meena S, C. MR. Prevalence of peripheral neuropathy and peripheral artery disease in diabetic patients attending a tertiary care hospital. Int J Adv Med 2019; 6: 1493.
Nada WM, Abdel-Moety DA. Evaluation of Serum and Aqueous Humor Vascular Endothelial Growth Factor in Neovascular Glaucoma. Open J Ophthalmol 2017; 07: 79–87.
Nomair A, ElDeeb MK, Maharem D. Aldose reductase (-106) C/T gene polymorphism and possibility of macrovascular complications in Egyptian type 2 diabetic patients. Indian J Endocrinol Metab 2016; 20: 648.
Oyenihi AB, Ayeleso AO, Mukwevho E, et al. Antioxidant strategies in the management of diabetic neuropathy. Biomed Res Int 2015; 2015: 515042.
Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017; 40: 136–154.
Putz Z, Martos T, Németh N, et al. Vitamin D and neuropathy. Orv Hetil 2013; 154: 2012–2015.
Saravanan KM, Kannan M, Meera P, et al. E3 ligases: a potential multi-drug target for different types of cancers and neurological disorders. Future Med Chem. Epub ahead of print January 2022. DOI: 10.4155/fmc-2021-0157.
SARAVANAN KM, SUNDARAM KM. EFFECT OF BROMOCRIPTINE IN DIABETES MELLITUS: A REVIEW. UTTAR PRADESH J Zool 2021; 1166–1170.
Senthil R, Meenakshi Sundaram K, Bupesh G, et al. Identification of oxazolo[4,5-g]quinazolin-2(1H)-one derivatives as EGFR inhibitors for cancer prevention. Asian Pacific J Cancer Prev.
Sheehan JP. Magnesium deficiency and diabetes mellitus. Magnes Trace Elem 2002; 10: 215–9.
Shera AS, Jawad F, Maqsood A, et al. Prevalence of chronic complications and associated factors in type 2 diabetes. J Pak Med Assoc 2004; 54: 54–9.
Sundaram KKM, Bupesh G, Saravanan KM. Instrumentals behind embryo and cancer: a platform for prospective future in cancer research. AIMS Mol Sci 2022; 9: 25–45.
Sundararaman, M N, Maruthanayagam V, et al. Tropical Marine Cyanobacterium Lyngbya sordida Producing Toxic Octacosa–1,27-diene Induces Coagulative Hepatic Necrosis and Progressive Glomerulonephritis in Mus musculus. In: Encyclopedia of Marine Biotechnology. John Wiley & Sons Ltd, 2020, pp. 2339–2364.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Tavakoli M, Gogas Yavuz D, Tahrani AA, et al. Diabetic Neuropathy: Current Status and Future Prospects. J Diabetes Res 2017; 2017: 5825971.
Tonali P. [Diabetic neuropathy]. Minerva Med 1976; 67: 270–9.
Udler MS. Type 2 Diabetes: Multiple Genes, Multiple Diseases. Curr Diab Rep 2019; 19: 55.
Vujkovic M, Keaton JM, Lynch JA, et al. Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet 2020; 52: 680–691.
WHO. Global health risks (2009). http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf. World Heal Organ 2009; 1–55.
Witzel I-I, Jelinek HF, Khalaf K, et al. Identifying Common Genetic Risk Factors of Diabetic Neuropathies. Front Endocrinol (Lausanne) 2015; 6: 1–10.
Yadav S, Ramesh V, Bhatia E, et al. A prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med 2014; 60: 270.
Yovera-Aldana M, Velásquez-Rimachi V, Huerta-Rosario A, et al. Prevalence and incidence of diabetic peripheral neuropathy in Latin America and the Caribbean: A systematic review and meta-analysis. PLoS One 2021; 16: e0251642.
Zakin E, Abrams R, Simpson DM. Diabetic Neuropathy. Semin Neurol 2019; 39: 560–569.
Zhang Q, Ji L, Zheng H, et al. Low serum phosphate and magnesium levels are associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2018; 146: 1–7.
Zhang X, Sun Z, Jiang H, et al. Relationship between single nucleotide polymorphisms in the 3’-untranslated region of the vascular endothelial growth factor gene and susceptibility to diabetic peripheral neuropathy in China. Arch Med Sci 2014; 5: 1028–1034.
Ziegler D, Strom A, Bönhof GJ, et al. Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy. BMJ open diabetes Res care 2019; 7: e000752.
Zitouni K, Tinworth L, Earle KA. Ethnic differences in the +405 and −460 vascular endothelial growth factor polymorphisms and peripheral neuropathy in patients with diabetes residing in a North London, community in the United Kingdom. BMC Neurol 2017; 17: 125.
Zochodne DW. Diabetic polyneuropathy: an update. Curr Opin Neurol 2008; 21: 527–33.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
